Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

导出原文传递

翻译打印收藏纠错

作者： Nywening, Timothy M. ^[1] ; Wang-Gillam, Andrea ^[2] ; Sanford, Dominic E. ^[3] ; Belt, Brian A. ^[4] ; Panni, Roheena Z. ; Cusworth, Brian M. ; Toriola, Adetunji T. ; Nieman, Rebecca K. ; Worley, Lori A. ; Yano, Motoyo ; Fowler, Kathryn J. ; Lockhart, A. Craig ; Suresh, Rama ; Tan, Benjamin R. ; Lim, Kian-Huat ; Fields, Ryan C. ; Strasberg, Steven M. ; Hawkins, William G. ; DeNardo, David G. ; Goedegebuure, S. Peter ; Linehan, David C.

作者单位： Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA ^[1] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA ^[2] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA ^[3] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA ^[4]

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

The lancet oncology

2016年17卷5期

651-662页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

The lancet oncology

相似文献

The lancet oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

The lancet oncology

相似文献

The lancet oncology

相关期刊

检索历史清除